MedTrace Logo

Zolmitriptane as Prophylaxis for Chilhood Migraine

NCT06089356 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-10-18

No results posted yet for this study

Summary

zolmitriptane can be tried as prophylactic therapy of childhood migraine

Conditions

Interventions

DRUG

zolmitriptanee

zolmitriptane tablet daily

DRUG

topiramate

topiramate once daily

DRUG

Valproate

valproate once daily

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Abeer Salamah, ass prof · kafrelsheikh university- egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06089356 on ClinicalTrials.gov